SOD1 and amyotrophic lateral sclerosis: Since the information about the role and the eventualmodifications occurring at the level of BAT in the ALS contexts are oftenfragmented and contradictory, we decided to fill this gap with a completecharacterization of BAT at the symptomatic stage of the disease, by amulti-omics approach involving both proteomics (ProteomeXchange identifierPXD054147) and RNA-Sequencing (GEO identifier GSE273052) analyses on BATtotal extracts from wild type and SOD1-G93A mouse model at symptomatic stageof 120 d.p.p.